Provides sterilization and irradiation services for medical device makers, pharmaceutical companies and food businesses, and sells radioactive cobalt sources and irradiation systems to sterilizers and manufacturers.
10-K for FY2025, filed Feb 24, 2026We are a leading global provider of outsourced terminal sterilization and irradiation services and have provided sterilization services for…View ↗
We offer our customers a complete range of terminal sterilization services, primarily using the three major commercial terminal…View ↗
Sterigenics primarily provides sterilization services for medical device manufacturers and the pharmaceutical industry and also provides…View ↗
Nordion is the leading global provider of Co-60 used in sterilization and irradiation processes for the medical device, pharmaceutical…View ↗
Co-60 is sold to customers by its level of radioactivity as measured in curies. Our customers typically buy low specific activity Co-60…View ↗
We also design, install and maintain gamma irradiation systems, which include radiation shielding, a series of conveyors and control…View ↗
Customers pay for sterilization and irradiation after processing is completed and approved; lab testing services are provided over time. Nordion sells cobalt sources when they are delivered, while gamma irradiation systems are generally paid for as the work progresses.
10-K for FY2025, filed Feb 24, 2026
10-K for FY2025, filed Feb 24, 2026
FY2025 revenue by product or service ↗$1.2B
10-K for FY2025, filed Feb 24, 2026
$1.2B ↗| Segment | Share | Revenue |
|---|---|---|
|
Service
|
86%
FY2022: 86%
|
Service, FY2025
$995.8M Sources
|
|
Product
|
14%
FY2022: 14%
|
Product, FY2025
$167.9M Sources
|
Sterilization services go to medical device makers, pharmaceutical companies, food and agricultural businesses, and advanced-materials customers. Nordion sells mainly to medical device manufacturers and gamma sterilization providers; the filing also identifies a customer of Nordion’s as a competitor of Sterigenics.
10-K for FY2025, filed Feb 24, 2026Sterigenics primarily provides sterilization services for medical device manufacturers and the pharmaceutical industry and also provides…View ↗
Sterigenics CustomersView ↗
Nordion primarily serves medical device manufacturers and gamma sterilization service providers. We are integral to our customers’…View ↗
One of Nordion’s customers is Sterigenics, which competes with several of Nordion’s other gamma sterilization service customers. When we…View ↗
Yes. It kept 7 cents of every revenue dollar as net income in FY2025 and turned 13 cents into free cash flow.
10-Q for Q3 FY2026, filed Nov 3, 2026
Open tableView ↗
8-K, filed Aug 6, 2026
Net revenues range raised to $1.236 billion to $1.254 billion, representing constant currency growth of 5.25% to 6.75% and an estimated 100…View ↗
8-K, filed May 5, 2026
In accordance with the Company’s executive succession plans, on May 5, 2026, the Company announced a leadership transition pursuant to…View ↗
Growing. Revenue grew 25% in 4 years, from $931.5M in FY2021 to $1.2B in FY2025, about 6% a year.
Competes with STERIS
10-K for FY2025, filed Feb 24, 2026We compete globally with Applied Sterilization Technologies, a segment of STERIS plc, as well as other smaller or regional outsourced…View ↗
Loading...